The partnership combines Secarna’s OligoCreator® technology with Vect-Horus’ VECTrans® platform to enable systemic delivery of oligonucleotide therapies across the blood-brain barrierThis ...

EQS-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word (s): Agreement Secarna Pharmaceuticals and Vect-Horus Announce Research Collaboration to Advance Systemic Delivery of RNA-Targeted ...

Missions in the upcoming Warhammer: The Horus Heresy are getting a few tweaks. Get ready for few Battle Rounds to score those VPs. I’ve voiced some concern about the length of games in the upcoming ...